Send feedback

ENG p.Pro528Leu

c.1583C>T · VCV3256967

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.091 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00267%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
hereditary hemorrhagic telangiectasia

Computational evidence

Protein change
AlphaMissense0.091likely benign
REVEL0.181moderately benign-leaning
SaProtLLR -7.86tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -0.23GERP -3.2
Regional constrainto/e 0.86unconstrained · MANE · 39 kb · p 5.2e-05 · regional, not allelic
Overall
CADD1.914PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00267% African / African-American · 2/74,920 alleles
Filtering AF 0.000443% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000211%
Overall 0.000929% 15/1,614,048 alleles · very rare exomes 13/1,461,870 · genomes 2/152,178 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,604
African / African-Americangrpmax 0.00267% 37,460
East Asian 0.00223% 44,886
South Asian 0.0022% 45,544
Remaining individualsnot grpmax-eligible 0.0016% 62,484
European (non-Finnish) 0.000678% 147,504

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ENG
Protein
p.Pro528Leu
Coding
c.1583C>T
MANE Select
NM_001114753
Type
single nucleotide variant
Location
chr9:127818223 (GRCh38)
Gene constraint
LOEUF 0.374 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 80.84 · 3 PDB
Residue 528
the zp domain
Full ENG gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary hemorrhagic telangiectasia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary hemorrhagic telangiectasia (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eng-p-pro528leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown